| close this window |
| Source: | LOHAS Weekly Newsletter |
| Published: | Friday, December 13, 2002 |
In March, HESG announced it planned to buy QBI in exchange for cash and stock. During 2001, QBI generated more than $12 million in revenues from product sales and contract work, according to an announcement in March.
HESG President Bill Glaser has said that the QBI acquisition will be instrumental to a planned launch for a line of integrative-medicine products that address ailments including heart disease, cold, flu, arthritis, migraine and allergies.